Rashmi K Murthy Selected Research

Rashmi K Murthy Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2012
13	Neoplasms (Cancer) 01/2023 - 12/2009
7	Triple Negative Breast Neoplasms 06/2023 - 04/2017
5	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2020
4	Pathologic Complete Response 01/2022 - 12/2018
4	Disease Progression 01/2020 - 09/2012
2	Residual Neoplasm 01/2023 - 11/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2009
2	Diarrhea 01/2020 - 07/2017
1	Nausea 01/2020
1	Vomiting 01/2020
1	Cardiotoxicity 01/2020
1	Inflammatory Breast Neoplasms 01/2020
1	Fatigue 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Anemia 07/2017
1	Hypokalemia 07/2017
1	Exanthema (Rash) 07/2017
1	Bone Diseases (Bone Disease) 12/2009
1	Osteolysis 12/2009
1	Multiple Myeloma 12/2009
1	Bone Resorption 12/2009

Drug/Important Bio-Agent (IBA)

12	Trastuzumab (Herceptin)FDA Link 01/2023 - 07/2014
5	Hormones (Hormone)IBA 01/2021 - 12/2018
4	Capecitabine (Xeloda)FDA Link 01/2023 - 07/2019
4	trastuzumab deruxtecanIBA 01/2023 - 01/2019
4	tucatinibIBA 01/2023 - 07/2017
4	human ERBB2 proteinIBA 01/2021 - 07/2014
3	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2019
3	pertuzumabIBA 01/2020 - 12/2018
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023 - 04/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2014
2	HER2 peptide (369-377)IBA 01/2021 - 01/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 07/2019
2	Transaminases (Aminotransferases)IBA 01/2020 - 07/2017
2	Lapatinib (GW572016)FDA Link 07/2019 - 01/2019
2	Letrozole (Femara)FDA LinkGeneric 07/2019 - 12/2018
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 12/2018
1	130-nm albumin-bound paclitaxelIBA 06/2023
1	AnthracyclinesIBA 06/2023
1	atezolizumabIBA 06/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	VaccinesIBA 01/2021
1	Estrogen ReceptorsIBA 10/2020
1	talazoparibIBA 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2020
1	thiamine triphosphorate (TTP)IBA 07/2019
1	telomerase RNA (bTR)IBA 07/2019
1	entinostat (MS 275)IBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Estrogens (Estrogen)FDA Link 12/2018
1	Imatinib Mesylate (Gleevec)FDA Link 12/2018
1	tipifarnib (R115777)IBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Bevacizumab (Avastin)FDA Link 04/2017
1	liposomal doxorubicin (Doxil)FDA Link 04/2017
1	Fluorouracil (Carac)FDA LinkGeneric 12/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012
1	AngiozymeIBA 09/2012
1	RANK LigandIBA 12/2009
1	OsteoprotegerinIBA 12/2009

Therapy/Procedure

12	Therapeutics 06/2023 - 12/2009
6	Drug Therapy (Chemotherapy) 11/2021 - 09/2012
4	Neoadjuvant Therapy 01/2023 - 01/2020
1	Investigational Therapies (Experimental Therapy) 11/2021
1	Biological Therapy 01/2021